A formidable opponent Alzheimer's Disease (AD), accounting for 60% of global dementia cases, faces a promising counter in the form of Reishi mushrooms, revealed by a groundbreaking study that aggregated hundreds of individual studies and extensive research. With neurodegenerative disorders predicted to become the second leading cause of death by 2040, Reishi emerges as a beacon of hope, largely due to its anti-amyloidogenic, antioxidant, anti-inflammatory, and neuroprotective properties. - Hallmarks of AD Characterized by the accumulation of β-amyloid plaques and neurofibrillary tangles composed of tau protein, disrupts cell communication and leads to neuronal damage. - Reishi’s neuroprotection Reishi mushrooms contain compounds like Ganoderic acid D and A, which protect brain cells from stress-induced damage and promote cellular health, showcasing potential as a neuroprotective agent against AD. - Anti-inflammatory and antioxidants Extracts from Reishi mushrooms have been demonstrated to reduce brain inflammation by inhibiting pathways responsible for it, supporting their role in combating inflammation-related aspects of AD. - Memory improvement Studies indicate that Ganoderic acid can enhance memory and brain function, suggesting Reishi’s compounds could be beneficial in treating brain-related diseases.